HIV drugmaker agrees to $40M settlement over claims it delayed treatment rollout
-----
Pharmaceutical giant Gilead said Tuesday it has agreed to pay $40 million to as many as 2,625 AIDS patients nationwide who say the company padded its profits by marketing a drug for years without disclosing that it had harmful side effects, and that it was delaying release of a safer alternative. The proposed federal court settlement does not affect a similar suit by 22,000 patients in California state court.The company, based in Foster City, insisted in a statement that it had done
